Glen Barber named director of Center for Innate Immunity and Inflammation at Ohio State’s Pelotonia Institute for Immuno-Oncology

Linda Liau elected to Taiwan’s Academia Sinica

Linda Liau, chair of neurosurgery at the David Geffen School of Medicine at UCLA, was elected as an Academician of Academia Sinica by the 35th Convocation of Academicians, the preeminent academic institution in Taiwan.

July 12, 2024

Vol.50 No.28

Clinical Roundup

CHK1 inhibitor + rheumatoid arthritis drug could be therapy for NSCLC

The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove Research Institute researchers have found a potentially effective drug-combination approach to treating certain patients with non-small cell lung cancer.

June 28, 2024

Vol.50 No.26

In Brief

Christian Rolfo named director of Ohio State Division of Medical Oncology

Christian Rolfo was named director of the Division of Medical Oncology at The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove Research Institute. He will start on Aug. 15.

June 21, 2024

Vol.50 No.25

Clinical Roundup

NLRC5 is an innate immune sensor that plays a crucial role in PANoptotic cell death

NLRC5 plays a previously unknown role as an innate immune sensor, triggering cell death, according to new research from St. Jude Children’s Research Hospital. The findings, published in Cell, show how NLRC5 drives PANoptosis, a prominent type of inflammatory cell death.

June 21, 2024

Vol.50 No.25

Clinical Roundup

Lifileucel shrinks tumors in mNSCLC in phase II trial

Researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute said results of a phase II, multi-center clinical trial revealed that a new type of cell therapy is a promising potential treatment option for patients with stage 4 lung cancer who were previously treated but later developed resistance to other therapies.

May 10, 2024

Vol.50 No.19

In Brief

Fatemeh Ardeshir, Andrew Srisuwananukorn receive ECOG-ACRIN Awards of Distinction

Fatemeh ArdeshirAndrew SrisuwananukornFatemeh Ardeshir and Andrew Srisuwananukorn, two presenters from the 23rd annual Young Investigator Symposium of the ECOG-ACRIN Cancer Research Group have received awards of distinction—a yearly tradition.

November 03, 2023

Vol.49 No.41

Glen Barber named director of Center for Innate Immunity and Inflammation at Ohio State’s Pelotonia Institute for Immuno-Oncology

YOU MAY BE INTERESTED IN

Linda Liau elected to Taiwan’s Academia Sinica

CHK1 inhibitor + rheumatoid arthritis drug could be therapy for NSCLC

Christian Rolfo named director of Ohio State Division of Medical Oncology

NLRC5 is an innate immune sensor that plays a crucial role in PANoptotic cell death

Lifileucel shrinks tumors in mNSCLC in phase II trial

Fatemeh Ardeshir, Andrew Srisuwananukorn receive ECOG-ACRIN Awards of Distinction

Renew today!

Subscriber content

Login